NewsRoom Articles - Page 42 of 251

MondayJan 10, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

FridayJan 07, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC" It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified Laboratory Flora Growth also made notable appointments to its executive leadership as well as its board of directors Flora Growth (NASDAQ: FLGC) had an impressive year in 2021, highlighted by the company’s Initial…

ThursdayJan 06, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with a projected value of $108.8 billion by 2027 The advertising and media contract will allow SRAX to engage and manage social media companies for the creation and distribution of advertising materials promoting Lexaria Bioscience Lexaria Bioscience (NASDAQ: LEXX), an innovator of drug delivery platforms, announced that it will kick off 2022 with an advertising and media agreement with SRAX (NASDAQ:…

WednesdayJan 05, 2022 1:05 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Named as One of the Top 101 Food and Beverage Startups and Companies in Canada

Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in Canada BevCanna was also recognized as one of the Top 101 Cannabis Startups in the country The company has had strong growth momentum in its core business, with 3Q21 revenues rising over 1,000% year-over-year BevCanna signed an agreement to manufacture and white-label cannabis beverages on behalf of Averi Health Products, which will subsequently be distributed in the Canadian market BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) — a diversified health & wellness beverage and natural products company developing and manufacturing a…

MondayJan 03, 2022 12:39 pm

Flora Growth Corp. (NASDAQ: FLGC) Entering 2022 with Momentum from Sustainability Efforts and the Building of Global Distribution Channels

Flora Growth Corp. is a Canadian cannabis and wellness brand distributor operating from a cultivation base in central Colombia The company’s focus on sustainability guides its efforts to market products that are beneficial to their local communities as well as the world at large Market analysts predict 2022 will see the global CBD skin care market segment alone grow with a CAGR of 24.8 percent The COVID-19 pandemic is continuing to drive expansion of online retail that affects the cosmetics sector as well as clothing, groceries and other avenues that may include the more-than-190 cannabis-derivative products produced by Flora Growth …

ThursdayDec 30, 2021 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Named Exclusive Water Partner for Canada’s Country Music Week 2021; BevCanna Named One of 101 Top Food and Beverage Startups and Companies in Canada

BevCanna Enterprises announced that its in-house brand, TRACE was designated as the exclusive water partner for the Country Music Week 2021 The TRACE brand features a range of products sourced from springs located deep within the Rocky Mountains; the product range includes Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water and Natural Flavor Sparkling Spring Water among others BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health & wellness beverage and…

TuesdayDec 28, 2021 9:30 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Reports Strong Third Quarter 2021 Financial Results; Sees Revenues Soar by Upwards of 1,000% YoY

BevCanna Enterprises recently published its unaudited financial results for the third quarter of 2021 The company recorded over 1,000% revenue growth year-over-year which separately recording positive gross profit for the quarter In addition to receiving its initial orders from the British Columbia, Alberta and Ontario Cannabis Distribution companies, BevCanna has also signed an agreement with UNFI Canada – thus leading to a significant expansion in its geographical distribution footprint across Canada BevCanna also announced the acquisition of Embark Health Inc, a leader in solventless cannabis extraction, as it actively diversifies from its core beverage manufacturing business BevCanna Enterprises (CSE: BEV)…

MondayDec 27, 2021 1:33 pm

Flora Growth Corp. (NASDAQ: FLGC) Marks 2021 Close with Product Diversification and Market Expansion

Flora Growth recently expanded into Mexico and Spain with its Mind Naturals and Awe CBD skincare brands Additionally, the company ventured into the dry herb market through Vessel brand, its wholly owned subsidiary The recent licensing agreement with Tonino Lamborghini marks Flora Growth’s aggressive product diversification plan that has defined its 2021 calendar year All the decisions and moves made by the company so far have been geared toward growing the company’s market share, expanding its market reach, and increasing value for its shareholders Flora Growth (NASDAQ: FLGC) completed its first traditional cannabis Initial Public Offering (“IPO”) in May 2021.…

MondayDec 27, 2021 1:14 pm

Marijuana Company of America Inc. (MCOA) Completes VBF Brands Acquisition, Highlighting Growth Strategy

Marijuana Company of America, Inc. has been expanding its portfolio in recent months through acquisitions and partnerships designed to enhance the company’s revenue stream MCOA’s trademarked hempsmart brand of CBD products has been joined by verticals including marijuana cultivator and distributor VBF Brands, CBD brands distributor cDistro, in-store advertiser VapeTV US, and other industry solutions The recent completion of VBF Brands’ acquisition grants MCOA efficiency and sustainable cultivation techniques in its product development Efforts to expand the legalization of recreational and medicinal marijuana at the federal level have been gaining steam again, portending significant opportunities for growth in 2022 As…

MondayDec 27, 2021 1:08 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expects Study Results to Show its Patented Tech’s Value in Treating Hypertension Patients

Lexaria Bioscience is preparing to file an Investigational New Drug application with the U.S. Food and Drug Administration for its patented technology’s use in treating hypertension (high blood pressure) The company has completed multiple studies of the benefits of DehydraTECH(TM), in combination with cannabidiol to combat hypertension conditions and consequentially benefit cardiovascular patients Lexaria recently announced that it is nearing completion of a third human study in which the company expects to further explore whether DehydraTECH-CBD successfully treats high pulmonary blood pressure A comprehensive six-week human clinical study is expected to begin soon Lexaria Bioscience (NASDAQ: LEXX) is nearing completion…

News and publishing service for hemp related companies

Contact us: 512.354.7000